How a Rural North Carolina Network Uses Technology to Coordinate Care
Impact Primary Care Network selected Innovaccer for its unified platform supporting care management and population health analytics
Impact Primary Care Network selected Innovaccer for its unified platform supporting care management and population health analytics
Recent incidents of rogue AI models infiltrating organizations underscore the growing threat
Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeutics, the engineered peptide gives Takeda a drug with blockbuster sales potential as the pharma company’s top overall product faces patent expirations. The post First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare…
The second webinar in our Digital Health Intelligence series explores how healthcare organizations can utilize AI not just for efficiency but to foster genuine patient engagement and strengthen human connections, emphasizing a patient-centered approach.
If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while better-mobilized peers pull ahead and the institution’s ability to fulfill its mission erodes The post AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation appeared first on MedCity…
By STEPHEN FARBER If you grew up in the 1980s, you probably remember Press Your Luck. Contestants stood in front of a flashing game board chanting, “Big bucks… no Whammies… STOP!” hoping the next square held cash instead of the mischievous cartoon character that erased everything they had won. For years, assembling your own medical…
Through collaboration with LeanTaaS and a dedicated steering committee, UofL Health enhanced OR efficiency
A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the infrastructure to properly test and validate them before they become embedded in patient care. The post Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up appeared first on MedCity…
Biohaven is outlicensing to SK Biopharmaceuticals global rights to opakalim, a Kv7-targeting small molecule in pivotal clinical testing for epilepsy. Biohaven gets non-dilutive financing for its pipeline while SK Bio gains another asset to potentially commercialize in the U.S. The post SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven appeared first on…
When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases, people wait too long, leaving an ER visit as the path of least resistance. The post The Missing Piece in Lowering the Cost of Care: Predictability appeared first on MedCity News.